Article Details
Retrieved on: 2024-10-31 19:45:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche (RHHBY) announced that a detailed analysis of the positive phase III INAVO120 results, evaluating Itovebi in combination with palbociclib .
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here